全球整形外科市場 - 2023-2030
市場調查報告書
商品編碼
1290386

全球整形外科市場 - 2023-2030

Global Plastic Surgery Market - 2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球整形外科市場在2022年達到697億美元,預計到2030年將見證有利可圖的成長,達到1587億美元。在預測期間(2023-2030年),全球整形外科市場預計將呈現11.1%的複合成長率。越來越多的技術進步和越來越多的新型產品的臨床試驗正在推動對整形手術的需求。

現在城裡最熱門的話題是美容或整形手術。通常被認為是安全的最小侵入性程序包括涉及填充物、神經毒素、雷射和能量設備的程序。根據美國美容整形外科協會的數據,30多歲的女性更頻繁地進行美容手術,30%的吸脂病人在19至34歲之間。

整形外科市場範圍包括外科手術類型,如重建外科手術、美容(審美)外科手術和美容微創手術,這增加了整形外科的市場佔有率。全球整形外科市場正在擴大,其因素包括不斷增加的研究和開發,以及各國各主要參與者即將批准的新產品。

市場動態

新產品的不斷推出推動了整形外科市場的成長

功能失調或不一致的情況,如先天性損傷或受傷,通過整形手術來解決。為了提高吸引力,採用了整容手術。根據美國美容外科學會的說法,整形手術是用來改善外觀或治療工作不正常的身體部位的。

例如,人們可能會選擇做整形手術,以協助修復嚴重的燒傷,或先天性的損傷,或在乳房切除後重建乳房。整容手術不是出於醫療原因而改善外觀,而是側重於美學考慮。人們可以接受整容手術,如拉皮或鼻子手術,以改變他們的臉部或身體的外觀。

2023年4月26日,Galderma公司披露,聚左旋乳酸(PLLA-SCA)的注射版Sculptra獲得了FDA的批准,可以解決臉頰周圍的皺紋以及細紋。 Sculptra成功地解決了微笑時的臉頰皺紋,持續時間長達2年,這是它的次要目標,其主要療效終點是休息時臉頰皺紋減少1級。因此,越來越多的新型產品的推出正在推動整形外科市場的發展。

不斷增加的臨床試驗和研究與開發為製造商創造了有利可圖的機會

一些研究人員或研究員對臨床研究和基礎科學研究的貢獻,加速了新型治療方法的開發,並大大改善了我們對疾病起源和過程的理解。正在進行的幾項臨床試驗取得了積極成果。

在巴黎舉行的2023年世界大會國際衰老科學大師班上,致力於提供突破性產品的以客戶為中心戰略的高性能美容公司Evolus, Inc.介紹了其II期臨床研究的中期數據,評估了其旗艦神經毒素產品Jeuveau(prabotulinumtoxinA-xvfs)的"超強度"創作,持續時間更長。根據結果,Jeuveau的"特強"配方為40U(單位),產生了6個月或26週的持續時間特徵。因此,這些因素將推動整形外科市場規模的成長。

與這些手術相關的高風險和併發症將阻礙市場的成長。

血腫是一種可觀的、令人不舒服的瘀傷,類似於一個血袋。這種結果發生在1-6%的隆胸手術中;它也可能作為拉皮手術的副作用發生。意外的是,你也可能需要額外的手術來清除血腫中的血液。這個問題幾乎總是在手術中發生。

此外,最常見的術後後果之一是感染。乳房手術後的蜂窩組織炎是一種潛在的併發症,可能影響2%至4%的病人。有些感染可能比其他感染更嚴重,需要靜脈注射抗生素。因此,上述因素限制了整形外科市場的成長。

COVID-19影響分析

各個行業的公司的財務健康都受到COVID-19大流行病和全世界眾多國家封鎖的影響。因此,在COVID-19公共衛生緊急情況期間,美國食品和藥物管理局(FDA)發布了指導方針,其中包括幫助贊助商和研究人員的一般注意事項,確保試驗參與者的安全,堅持良好的臨床實踐(GCP),並儘量減少試驗完整性的風險。

俄烏戰爭影響分析

俄羅斯-烏克蘭衝突估計對全球整形外科市場的影響不大,因為該地區的主要市場參與者數量較少。然而,在預測期內,原料進出口的影響預計對全球整形外科市場的成長影響不大。

目錄

第一章:方法和範圍

  • 研究方法
  • 報告的研究目標和範圍

第二章:定義和概述

第三章:執行摘要

  • 按外科手術類型分析
  • 按性別分類的摘要
  • 按年齡層分類
  • 按終端用戶分類
  • 按地區分類

第4章:動態變化

  • 影響因素
    • 驅動因素
      • 新產品發布的增加
      • 越來越多的臨床試驗和研究與開發
    • 限制因素
      • 與這些手術相關的高風險和併發症
    • 機會
      • 媒體、社交媒體和時尚行業的影響力不斷上升
    • 影響分析

第五章:行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 監管分析

第六章:COVID-19分析

  • COVID-19的分析
    • COVID-19之前的情況
    • COVID-19期間的情況
    • COVID-19之後的情況
  • 在COVID-19期間的定價動態
  • 需求-供應譜系
  • 大流行期間與市場有關的政府計劃
  • 製造商的戰略計劃
  • 結語

第七章:按外科手術類型分類

  • 重建性外科手術
    • 腫瘤切除手術
    • 損傷修復
    • 頜面手術
    • 疤痕修復
    • 手部手術
    • 其他手術
  • 化妝(美學)手術
    • 豐胸
    • 鼻部整形
    • 吸脂術
    • 臉部提升
    • 眼瞼手術
    • 身體塑形
    • 皮膚再生
    • 其他
  • 微創美容程序
    • A型肉毒桿菌毒素
    • 軟組織填充劑
    • 雷射換膚
    • 化學換膚
    • 強脈衝光治療
    • 雷射脫皮
    • 其他

第8章:按性別分類

  • 女性
  • 男性

第九章:按年齡層分類

  • 年齡層(13-19歲)
  • 年齡層(20-29歲)
  • 年齡層(30-39歲)
  • 年齡層(40-54歲)
  • 年齡層(55-69歲)
  • 年齡層(70歲以上)

第十章:按終端用戶

  • 醫院
  • 外科中心/診所
  • 其他

第十一章:按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
      • 亞太其他地區
  • 中東和非洲
    • 關鍵區域的動態

第十二章:競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 合併和收購分析

第十三章:公司簡介

  • Allergan Aesthetics (AbbVie Inc.)
    • 公司概述
    • 產品組合和說明
    • 財務概況
    • 主要發展情況
  • Alma Lasers
  • Cynosure LLC
  • Galderma
  • Bausch Health Companies Inc.
  • Merz Aesthetics
  • Candela Corporation
  • Evolus, Inc.
  • Lumenis Be Ltd.
  • GC Aesthetics

第十四章:附錄

簡介目錄
Product Code: MD443

Market Overview

The Global Plastic Surgery Market reached US$ 69.7 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 158.7 billion by 2030. The global plastic surgery market is expected to exhibit a CAGR of 11.1% during the forecast period (2023-2030). The increasing technological advancements and the growing clinical trials for novel products are driving demand for plastic surgery.

The hottest topics in town right now are cosmetic or plastic procedures. The least invasive procedures that are generally deemed safe include those involving fillers, neurotoxins, lasers, and energy devices. According to the American Society for Aesthetic Plastic Surgery, women in their 30s are having cosmetic operations performed more frequently, and 30% of liposuction patients are between the ages of 19 and 34.

The plastic surgery market scope comprises surgical procedure types such as reconstructive surgical procedures, cosmetic (aesthetic) surgical procedures, and cosmetic minimally-invasive procedures, which has increased the plastic surgery market share. The global market for plastic surgery is expanding as a result of factors including increasing research and development and the upcoming novel product approvals by various key players across countries.

Market Dynamics

The Rising Novel Product Launches Drive the Growth of the Plastic Surgery Market

Instances of dysfunction or inconsistency, such as congenital impairments or injuries, are addressed by plastic surgery. In order to improve the attractiveness, cosmetic surgery is used. According to the American Academy of Cosmetic Surgery, plastic surgery is used to improve the look or treat bodily parts that are not working properly.

One might choose to have plastic surgery, for instance, to assist repair serious burns, or congenital impairments, or to rebuild the breast following a mastectomy. Instead of improving the look for medicinal reasons, cosmetic surgery focuses on aesthetic considerations. People may undergo cosmetic surgery, such as a facelift or nose surgery, to alter the appearance of their face or body.

On April 26, 2023, Galderma disclosed that Sculptra, an injectable version of poly-L-lactic acid (PLLA-SCA), was given FDA approval to address wrinkles as well as fine lines around the cheeks. Sculptra successfully addressed cheek wrinkles during smiling for up to two years, which was its secondary goal, and its main efficacy endpoint of a 1-grade reduction in cheek wrinkles at rest. Hence, the growing number of novel product launches is driving the plastic surgery market.

Rising Clinical Trials and Research and Development Create Lucrative Opportunities for Manufacturers

Contributions to clinical research and fundamental science research from a number of researchers or fellows have accelerated the development of novel treatments and significantly improved our understanding of the origins and course of the disease. Several clinical trials are being conducted resulting in positive outcomes.

At the World Congress International Master Course on Aging Science 2023 in Paris, Evolus, Inc., a performance beauty company with a customer-centric strategy committed to delivering ground-breaking products, presented interim data from its Phase II clinical study evaluating an "extra-strength" creation for a longer duration of Jeuveau (prabotulinumtoxinA-xvfs), its flagship neurotoxin product. According to the results, Jeuveau's "extra-strength" formulation at 40U (units) produced a duration profile of six months or twenty-six weeks. Thus, these factors will drive the growth of the plastic surgery market size.

High Risks and Complications Associated with These Surgeries will Hamper the Growth of the Market.

Hematoma is a sizable, uncomfortable bruise that resembles a bloody pocket. This outcome happens in 1 to 6% of breast augmentation surgeries; it can also happen as a side effect of a facelift. Unexpectedly, you might also require additional surgery to remove the blood from a hematoma. This problem occurs almost always during operations.

Furthermore, one of the most frequent postoperative consequences is infection. Cellulitis following breast surgery is a potential complication that may affect 2 to 4 percent of patients. Some infections could be more serious than others and call for intravenous antibiotics. Hence, the above mentioned factors are limiting the plastic surgery market's growth.

COVID-19 Impact Analysis

The financial health of companies across all industries has been impacted by the COVID-19 pandemic and lockdown in numerous nations throughout the world. Therefore, during the period of the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) issued guidelines that include general considerations to aid sponsors and researchers, ensuring the safety of trial participants, adhering to good clinical practice (GCP), and minimizing risks to trial integrity.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a low impact on the global plastic surgery market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global plastic surgery market growth over the forecast period.

Segment Analysis

The global plastic surgery market is segmented based on surgical procedure type, gender, age group, end user and region.

Age Group (30-39) Segment Accounts for 38.1% of the Market Share Owing to the Rising Adoption of Plastic Surgery by This Age Group

Historically, everyone between the ages of 18 and 70 was considered a good candidate for plastic surgery. This is due to the fact that most cosmetic operations perform at their peak once the body has reached its full adult size. Males typically attain adult size between ages 15 and 18, whilst girls typically do so between ages 14 and 18.

Up to 1 million Botox treatments are performed annually on people in this age group, making them the most popular cosmetic procedure. Liposuction or breast augmentation comes next. The "Mommy Makeover" is often chosen by women who are finished having children. This entails a thorough range of procedures designed to get the body back to how it was before getting pregnant. They consist of liposuction, breast lift procedures, and stomach tucks.

The 30-45 age group has the highest rate of cosmetic enhancement procedures performed (42.9% annually), making them the highest likely demographic. Anti-aging and body reshaping operations are among the most common for this age range.

Geographical Analysis

North America Accounted for Approximately 43.9% of the Market Share Owing to the Strong Presence of Major Players and Increasing Technological Advancements

Manufacturers have chances to expand their operations in this region because of the rising demand for plastic surgery for advancements in North America. The area has many producers and suppliers, and its rapid economic development has increased the industrial production of plastic surgery, which has increased the demand.

There are many manufacturers and suppliers in North America, and as a result of the region's rapid economic growth, industrial production has expanded, feeding the desire for cosmetic surgery.

The market will grow as new items or technology for surgeries emerge. Rising technological developments, governmental approvals, and the introduction of new products all contribute to growth. Researchers are becoming more aware of their physical appearance, looks, body shape and many more factors related to their appearance, leading to the expansion of the market in this region. These factors show the dominance of North America.

Competitive Landscape

The major global players in the plastic surgery market include: Allergan Aesthetics (AbbVie Inc.), Cynosure LLC, Alma Lasers, Galderma, Merz Aesthetics, Lumenis Be Ltd., Candela Corporation, Bausch Health Companies Inc., Evolus, Inc. and GC Aesthetics among others.

Why Purchase the Report?

  • To visualize the global plastic surgery market segmentation based on surgical procedure type, gender, age group, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of plastic surgery market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global plastic surgery market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Surgical Procedure Type
  • 3.2. Snippet by Gender
  • 3.3. Snippet by Age Group
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Rising Novel Product Launches
      • 4.1.1.2. Rising Clinical Trials and Research and Development
    • 4.1.2. Restraints
      • 4.1.2.1. High Risk and Complications Associated with these Surgeries
    • 4.1.3. Opportunity
      • 4.1.3.1. Rising Influence of Media, Social Media and the Fashion Industry
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Surgical Procedure Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
    • 7.1.2. Market Attractiveness Index, By Surgical Procedure Type
  • 7.2. Reconstructive Surgical Procedure *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Tumor Removal Surgery
    • 7.2.4. Laceration Repair
    • 7.2.5. Maxillofacial Surgery
    • 7.2.6. Scar Revision
    • 7.2.7. Hand Surgery
    • 7.2.8. Others
  • 7.3. Cosmetic (aesthetic) Surgical Procedure
    • 7.3.1. Breast Enhancement
    • 7.3.2. Nose Reshaping
    • 7.3.3. Liposuction
    • 7.3.4. Face Lift
    • 7.3.5. Eye-lid Surgery
    • 7.3.6. Body Contouring
    • 7.3.7. Skin Rejuvenation
    • 7.3.8. Others
  • 7.4. Cosmetic Minimally-Invasive Procedures
    • 7.4.1. Botulinum Toxin Type A
    • 7.4.2. Soft Tissue Filler
    • 7.4.3. Laser Skin Resurfacing
    • 7.4.4. Chemical Peel
    • 7.4.5. Intense Pulsed Light Treatment
    • 7.4.6. Laser Skin Removal
    • 7.4.7. Others

8. By Gender

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 8.1.2. Market Attractiveness Index, By Gender
  • 8.2. Female *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Male

9. By Age Group

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.1.2. Market Attractiveness Index, By Age Group
  • 9.2. Age Group (13-19) *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Age Group (20-29)
  • 9.4. Age Group (30-39)
  • 9.5. Age Group (40-54)
  • 9.6. Age Group (55-69)
  • 9.7. Age Group (70+)

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Surgical Centers/ Clinics
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Spain
      • 11.3.7.5. Italy
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan

Australia

      • 11.5.7.4. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Allergan Aesthetics (AbbVie Inc.) *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Alma Lasers
  • 13.3. Cynosure LLC
  • 13.4. Galderma
  • 13.5. Bausch Health Companies Inc.
  • 13.6. Merz Aesthetics
  • 13.7. Candela Corporation
  • 13.8. Evolus, Inc.
  • 13.9. Lumenis Be Ltd.
  • 13.10. GC Aesthetics

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us